Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine.

Autor: Corcorran MA; From the Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA (MAC, AMJ, NDF, EH, SNG); Department of Health Systems and Population Health, University of Washington, Seattle, WA (EJA, ESB, MCF, ECW); Department of Population Health Sciences, Weill Cornell Medical College, New York, NY (CNB, SNK, BRS); Health Services Research and Development Center of Innovation for Veteran-Centered and Value-Driven Care, Veterans Affairs Puget Sound Health Care System, Seattle, WA (MCF, ECW); Dave Purchase Project, North American Syringe Exchange Network, Tacoma, WA (SMP, PAL); Division of Infectious Diseases, Weill Cornell Medical College, New York, NY (SNK); Center for Drug Use and HIV Research, New York, NY (DCP); Division of Infectious Diseases, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, New York, NY (DCP); and School of Global Public Health, New York University, New York, NY (DCDJ)., Austin EJ, Behrends CN, Briggs ES, Frost MC, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC, Williams EC, Glick SN
Jazyk: angličtina
Zdroj: Journal of addiction medicine [J Addict Med] 2023 Jan-Feb 01; Vol. 17 (1), pp. e36-e41. Date of Electronic Publication: 2022 Aug 02.
DOI: 10.1097/ADM.0000000000001036
Abstrakt: Background: We explored syringe service program (SSP) perspectives on barriers, readiness, and programmatic needs to support coronavirus disease 2019 (COVID-19) vaccine uptake among people who use drugs.
Methods: We conducted an exploratory qualitative study, leveraging an existing sample of SSPs in the United States. Semistructured, in-depth interviews were conducted with SSP staff between February and April 2021. Interviews were analyzed using a Rapid Assessment Process, an intensive, iterative process that allows for rapid analysis of time-sensitive qualitative data.
Results: Twenty-seven SSPs completed a qualitative interview. Many SSP respondents discussed that COVID-19 vaccination was not a priority for their participants because of competing survival priorities, and respondents shared concerns that COVID-19 had deepened participant mistrust of health care. Most SSPs wanted to participate in COVID-19 vaccination efforts; however, they identified needed resources, including adequate space, personnel, and training, to implement successful vaccine programs.
Conclusions: Although SSPs are trusted resources for people who use drugs, many require additional structural and personnel support to address barriers to COVID-19 vaccination among their participants. Funding and supporting SSPs in the provision of COVID-19 prevention education and direct vaccine services should be a top public health priority.
Competing Interests: The authors report no conflicts of interest.
(Copyright © 2022 American Society of Addiction Medicine.)
Databáze: MEDLINE